Biosimilars 2015

Interact with FDA and international agencies to discuss the latest updates and outlooks for biosimilar regulation, while examining the potential implications for patients and HCPs.

返回 Agenda

Session Chair(s)

Sundar Ramanan, PhD

Director, Global Biosimilars R&D Policy

Amgen Inc., United States

Speaker(s)

Panelists

Joseph L Glajch

Momenta Pharmaceuticals, United States

Director, Analytical Development

Steven Kozlowski, MD

FDA, United States

Director, Office of Biotechnology Products, OPQ, CDER

Paul Tebbey, PhD, MBA

AbbVie, Inc., United States

Therapeutic Area Lead, Biotherapeutics Global Medical Affairs

Brad Jordan, PhD

Eli Lilly and Company, United States

Associate Vice President, Regulatory Policy and Strategy